RESEARCH-USE BIOSIMILAR ANTIBODY
Bococizumab
Monoclonal antibody · IgG2
Bococizumab (PF-04950615) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab can be used in the research of hypercholesterolemia.
TARGETPCSK9
YMonoclonal antibody
CATALOGSC-BS-717
CATALOG NUMBERSC-BS-717
MOLECULAR WEIGHTApprox. 145.06 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Bococizumab (PF-04950615) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab can be used in the research of hypercholesterolemia.
Bococizumab is a recombinant research-use antibody directed against PCSK9.